Fluoropolymers in Healthcare Market
Market Insights on Fluoropolymers in Healthcare covering sales outlook, demand forecast & up-to-date key trends
Fluoropolymers in Healthcare Market By Product Type (PTFE, PVDF, PVF, FEP, PCTFE, PFA), Application (Medical Devices, Hospital Disposable, Pharma Packaging) & Region - Forecast to 2020-2030
Introduction
New materials that exhibit suitable properties for particular application have resulted in increasing interest among healthcare professionals and patients over past few decades.
Among them, fluoropolymers (FP) are relevant niche candidates that are equipped with favorable properties such as chemical inertness (to oils, solvents, and acids), thermal stability, and durability.
Increased emphasis on health and hygiene to avoid potential COVID-19 contagion has bolstered sales of various hospital disposables. In addition, governments and health authorities are leveraging federal powers to influence manufacturers to ramp up production of hospital disposables at significant pace.
As such, the COVID-19 pandemic has fueled sales of hospital disposables and medical equipment as epidemiological numbers continue to surge. These trends will work in favor of fluoropolymers in healthcare market. By 2030, sales of fluoropolymers in healthcare industry will register revenues over US$ 900 Mn.
Let us know your requirement to get
100% FREE customization
Growing Focus Toward Medical Devices
The global medical device industry is witnessing tech-enabled advances and continuous innovations. As such, investments in R&D in this domain have surged by nearly 2X over recent past.
According to recent estimates, firms in medical device industry spend about 7% of their yearly revenue on R&D activities, echoing competitive nature of this sphere. Further, these estimates suggest that adoption of fluoropolymers in medical devices is prominent in developed regions, especially the US.
While hospital disposables and pharma packaging have been conventional applications for fluoropolymer manufacturers, adoption in medical devices such as catheters, and introducers will rise at rapid CAGR in coming years.
Expanding Revenue Pool
The COVID-19 pandemic and subsequent rising hospital admissions across the globe have considerably fueled the demand for medical disposables. The World Health Organization (WHO) has instructed industries and regulatory bodies to scale up manufacturing of personal protective equipment (PPE) such as medical gloves, hospital gowns, and face shields by 40% to cater to increasing global demand.
FMI also finds that rise in demand for such accessories has fueled their prices significantly. Case in point, price of hospital gowns has surged two-fold and that of surgical masks has increased six-fold. Further, the WHO has shipped nearly 500, 000 sets of PPE to about 47 countries. As such, sales of fluoropolymers have seen notable rise during the COVID-19 pandemic.
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystRegion-wise Analysis
East Asia Fluoropolymers in Healthcare Market
East Asia continues to engage stakeholders in fluoropolymers in healthcare market over following decade. The WHO reveals that 10 out of every 100 hospitalized patients in developing countries at any given time will acquire at least one healthcare-associated infection (HAI). Further, prevalence of HAIs is significantly higher in middle- and low-income countries (LMIC).
In addition, East Asia has been among the worst affected regions by COVID-19 pandemic. China and South Korea have registered notable rise in prevalence of COVID-19 spread. Densely populated pockets in these regions are triggering the risk for community transmission of the virus.
These broad factors will drive East Asia fluoropolymers in healthcare market. While China and South Korea collectively capture around 90% of overall regional market value, Japan will reflect potential growth prospects.
Europe Fluoropolymers in Healthcare Market
Europe follows East Asia in global fluoropolymers in healthcare market in terms of revenue share and CAGR. Pharmaceutical industry is among key-performing high-tech industries in Europe.
Medicines regulatory system of the region is based on network of 50 regulatory bodies from the European Commission, 31 European Economic Area (EEA) countries, and the European Medicines Agency (EMA).
Plastic bottles are utilized in large quantities for oral medicines distributed via prescription and bulk dose volumes to retail and mail order pharmacies. Moreover, plastic bottles find immense use in several applications as containers for over-the-counter (OTC) drugs distributed in capsules and tablets.
While Germany represents fluoropolymers in healthcare market in Europe, players are also generating substantial revenues from Italy and the UK.
An unified Market Research Subscription Platform, built for today’s disparate research needs.
North America Fluoropolymers in Healthcare Market
The fluoropolymers in healthcare market in North America is receiving major impetus from notable rise in hospital acquired infections (HAIs) and medical surgeries. HAIs result in myriads of mortalities and cost the US healthcare system significantly every year.
As such, the US Department of Health and Human Services (HHS) has recognized reduction of HAIs as Agency Priority Goal (APG). In addition, the US tops the list of active COVID-19 cases, thus, triggering the demand for hospital disposables. This, in turn, will drive adoption of fluoropolymers in healthcare systems.
The US will remain at forefront of regional market, as the country account for sales of about 9 out of 10 fluoropolymers, while market in Canada will fade in coming years.
Category-wise Insights
Product
About half of medical equipment globally contains polytetrafluoroethylene (PTFE) or teflon coatings, owing to their umpteen resistance against corrosion and various chemical agents. Healthcare professionals generally prefer medical equipment that are coated with teflon. In laboratories, teflon plays crucial role in maintaining safe and bacteria-free environment.
Moving ahead, in certain labs, microbial cultures are created for research purposes. Myriads of utensils utilized by healthcare professionals as well as platforms and analyzing tables are coated with teflon as the material does not impede development of bacteria and microbes.
Application
Increasing prevalence of HAIs and pandemic-related diseases has compelling consumers to resort to hospital disposables. The US Department of Health & Human Services (HHS) states that about 4% of total inpatients suffer from infection due to hospital care, at any given time.
Moreover, sales of hospital disposables have reached their peak amidst the COVID-19 pandemic. Among hospital disposables, medical gloves and blood bags continue to account for greater demand. Moving ahead, market players will hurt their revenue pool if they do not place their bets on medical devices.
Competitive Intelligence
Top 10 players capture about 40-45% of overall revenue. Fluoropolymer manufacturers are focusing on developing multipurpose products such as standard as well as customized or compounded products.
In addition, they are looking to equip their offerings with innovate technologies to cater to high-end applications. Mergers & acquisitions (M&A) will be another key focus point for global market players.
DIC Corporation has developed novel polyester plasticizer made from biomass resources and has earned the “Biomass 100%” Biomass Mark.
Korean joint venture - Mitsui Chemicals & SKC Polyurethanes Inc. – has manufactured ECONYKOL™ bio-polyol, which is raw material for plant-sourced biomass plastics that help curb ecological impact. The product has been adopted for polyurethane (PU) cushioning in seats of Robocar™ self-driving car.
Honeywell International Inc. has launched breakthrough platform of liquid heat transfer agents that cool high-performance electronics more effectively compared to conventional techniques that utilize water and air. IN addition, the company has rolled out 30 Series IP Cameras, which is a new set of video cameras that steps up infrastructure safety and security via advanced analytics and secure channel encryption.
3M Company has acquired Acelity, Inc. and its KCI subsidiaries. Further, the company has entered into royalty-bearing patent license agreement with LG-Innotek (LGIT) to leverage 3M’s metal mesh technology.
Daikin Industries Ltd. has acquired Heroflon, whose product assembly consists of micro-powders and fluoropolymer compounds derived from PTFE.
Lonza has entered into collaboration with Mesoblast to commercially develop Mesoblast’s lead allogeneic (off-the-shelf) cell therapy product - remestemcel-L - for pediatric steroid-refractory acute graft versus host disease (aGVHD).
In addition to these, some other key players in fluoropolymers in healthcare market include
- DIC Corporation
- AGC Inc.
- Dongyue Group Ltd.
- Solvay S.A.
- PolyOne Corporation
- Kaneka Corp.
- Arkema Group
- Saint Gobain S.A.
- The Chemours Company
Fluoropolymers in Healthcare Market Report: Scope
|
Attribute |
Details |
|
Forecast Period |
2020-2030 |
|
Historical Data Available for |
2015-2019 |
|
Market Analysis |
USD Million for value and Tons for Volume |
|
Key Regions Covered |
North America, Latin America, Europe. South Asia & Pacific, East Asia, and Middle East & Africa (MEA) |
|
Key Countries Covered |
US, Canada, Brazil, Mexico, Germany, UK, France, Italy, Spain, BENELUX, China, Japan, South Korea, India, ASEAN, Australia, New Zealand, GCC Countries, Turkey, Northern Africa, Israel, South Africa |
|
Key Segments Covered |
Product, Application, and Region |
|
Key Companies Profiled |
DIC Corporation, AGC Inc., Solvay S.A., Daikin Industries Ltd., Honeywell International Inc., Arkema Group, 3M Company, and The Chemours Company (only indicative list) |
|
Report Coverage |
Market Forecast, brand share analysis, competition intelligence, DROT analysis, Market Dynamics and Challenges, Strategic Growth Initiatives |
|
Customization & Pricing |
Key Segments
Product Type:
- PTFE
- PVDF
- PVF
- FEP
- PCTFE
- PFA
- Others
Application:
- Medical Devices
- Hospital Disposable
- Pharma Packaging
Regional Outlook:
- North America (US, and Canada)
- Latin America (Brazil, and Mexico)
- Europe (Germany, UK, Russia, France, and Italy)
- South Asia & Pacific (India, Indonesia, Thailand, Australia and New Zealand)
- East Asia (China, Japan, and South Korea)
- Middle East & Africa (MEA) (Turkey, GCC Countries, and South Africa)
Frequently Asked Questions
The global fluoropolymers in healthcare market will value around US$ 927 Mn in 2030. The growth rate for the market will be 4.7 % CAGR during 2020-2030.
East Asia represents the largest market globally, followed by Europe, owing to rising government investments in patient-centric care models.
The market is fairly consolidated with leading players including, DIC Corporation, AGC Inc., and Solvay S.A., accounting for prominent share in market revenue.
Companies generally offer fluoropolymers in healthcare for several applications such as medical devices, hospital disposables, and pharma packaging. While adoption in hospital disposables will remain high, usage in pharma packaging will pick momentum in coming years.
Market players continue to bank on polytetrafluoroethylene (PTFE) as preferred fluoropolymers. That said, they are also turning to polyvinyl fluoride (PVF) and perfluoroalkoxy alkanes (PFA).
Table of Content
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Technology Roadmap
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Taxonomy
2.2. Market Definition
3. Key Market Trends
3.1. Key Trends Impacting the Market
3.2. Development Trends
4. Key Success Factors
4.1. Strategic Promotional Strategies
5. Global Fluoropolymers Market for Healthcare Demand Analysis 2015 – 2019 and Forecast, 2020 – 2030
5.1. Historical Market Volume (Tons) Analysis, 2015 – 2019
5.2. Current and Future Market Volume (Tons) Projections, 2020 – 2030
5.3. Y-o-Y Growth Trend Analysis
6. Global Fluoropolymers Market for Healthcare - Pricing Analysis
6.1. Regional Pricing Analysis By product Type
6.2. Pricing Break-up
6.2.1. Manufacturer Level Pricing
6.2.2. Distributor Level Pricing
6.3. Global Average Pricing Analysis Benchmark
7. Global Market Demand (US$ Mn) Analysis 2015 – 2019 and Forecast, 2020 – 2030
7.1. Historical Market Value (US$ Mn) Analysis, 2015 – 2019
7.2. Current and Future Market Value (US$ Mn) Projections, 2020 – 2030
7.2.1. Y-o-Y Growth Trend Analysis
7.2.2. Absolute $ Opportunity Analysis
8. Market Background
8.1. Macro-Economic Factors
8.1.1. Chemical Industry Outlook
8.1.2. Global GDP Outlook
8.1.3. Global Healthcare Market Overview
8.1.4. Other Industrial Value Added Industry
8.2. Forecast Factors - Relevance & Impact
8.2.1. Top Companies Historical Growth
8.2.2. Demand From Chemicals Companies
8.2.3. Demand from Construction Industry
8.3. Global Urbanization Growth Outlook
8.4. Value Chain
8.4.1.1. List of Manufacturers
8.4.1.2. List of Suppliers
8.4.1.3. List of End Users
8.5. Supply Demand Analysis
8.5.1.1. Production Capacity Analysis
8.5.1.2. Production Analysis By Region
8.5.1.3. Consumption Analysis By Region
8.5.1.4. Net Trade Analysis
8.6. Import Vs Sales Price Analysis
8.7. Raw Material Analysis
8.7.1.1. Availability
8.7.1.2. List of Substitute Materials
8.8. Product Type Vs End-use Criss-cross Analysis
8.9. Market Dynamics
8.9.1. Drivers
8.9.2. Restraints
8.9.3. Opportunity Analysis
9. Global Fluoropolymers Market for Healthcare Analysis 2015 – 2019 and Forecast 2020 – 2030, By Product Type
9.1. Introduction / Key Findings
9.2. Historical Market Size (US$ Mn) and Volume Analysis By Product Type, 2015 – 2019
9.3. Current and Future Market Size (US$ Mn) and Volume Analysis and Forecast By Product Type, 2020 – 2030
9.3.1. Polytetrafluoroethylene (PTEF)
9.3.2. Polyvinylidene Fluoride (PVDF)
9.3.3. Polyvinyl Fluoride (PVF)
9.3.4. Fluorinated Ethylene Propylene (FEP)
9.3.5. Polychlorotrifluoroethylene (PCTFE)
9.3.6. Perfluoroalkoxypolymer (PFA)
9.3.7. Others
9.4. Market Attractiveness Analysis By Product Type
10. Global Fluoropolymers Market for Healthcare Analysis 2015 – 2019 and Forecast 2020 – 2030, By Application
10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ Mn) and Volume Analysis By Application, 2015 – 2019
10.3. Current and Future Market Size (US$ Mn) and Volume Analysis and Forecast By Application, 2020 – 2030
10.3.1.1. Medical Devices
10.3.1.2. Catheter
10.3.1.3. Introducer
10.3.1.4. Others
10.3.2. Hospital Disposable
10.3.2.1. Medical Gloves
10.3.2.2. Blood Bags
10.3.2.3. Surgical Drape Set
10.3.2.4. Others
10.3.3. Pharma Packaging
10.3.3.1. Vials
10.3.3.2. Bottles
10.3.3.3. Blister Packaging
10.3.3.4. Syringes
10.3.3.5. Others
10.4. Market Attractiveness Analysis By Application
11. Global Fluoropolymers Market for Healthcare Analysis 2015 – 2019 and Forecast 2020 – 2030, by Region
11.1. Introduction
11.2. Historical Market Size (US$ Mn) and Volume Analysis By Region, 2015 – 2019
11.3. Current Market Size (US$ Mn) and Volume Analysis and Forecast By Region, 2020 – 2030
11.3.1. North America
11.3.2. Latin America
11.3.3. Europe
11.3.4. East Asia
11.3.5. South Asia
11.3.6. Middle East and Africa (MEA)
11.4. Market Attractiveness Analysis By Region
12. North America Fluoropolymers Market for Healthcare Analysis 2015 – 2019 and Forecast 2020 – 2030
12.1. Introduction
12.2. Pricing Analysis
12.3. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2015 – 2019
12.4. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2018 - 2028
12.4.1.1. By Country
12.4.1.2. U.S.
12.4.1.3. Canada
12.4.2. By Product Type
12.4.3. By Application
12.5. Market Attractiveness Analysis
12.5.1. By Country
12.5.2. By Product Type
12.5.3. By Application
12.6. Market Trends
12.7. Key Market Participants - Intensity Mapping
12.8. Drivers and Restraints - Impact Analysis
13. Latin America Fluoropolymers Market for Healthcare Analysis 2015 – 2019 and Forecast 2020 – 2030
13.1. Introduction
13.2. Pricing Analysis
13.3. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2015 – 2019
13.4. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2018 - 2028
13.4.1.1. By Country
13.4.1.2. Brazil
13.4.1.3. Mexico
13.4.1.4. Rest of Latin America
13.4.2. By Product Type
13.4.3. By Application
13.5. Market Attractiveness Analysis
13.5.1. By Country
13.5.2. By Product Type
13.5.3. By Application
13.6. Market Trends
13.7. Key Market Participants - Intensity Mapping
13.8. Drivers and Restraints - Impact Analysis
14. Europe Fluoropolymers Market for Healthcare Analysis 2015 – 2019 and Forecast 2020 – 2030
14.1. Introduction
14.2. Pricing Analysis
14.3. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2015 – 2019
14.4. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2018 - 2028
14.4.1.1. By Country
14.4.1.2. Germany
14.4.1.3. Italy
14.4.1.4. France
14.4.1.5. U.K.
14.4.1.6. Spain
14.4.1.7. Russia
14.4.1.8. Rest of Europe
14.4.2. By Product Type
14.4.3. By Application
14.5. Market Attractiveness Analysis
14.5.1. By Country
14.5.2. By Product Type
14.5.3. By Application
14.6. Market Trends
14.7. Key Market Participants - Intensity Mapping
14.8. Drivers and Restraints - Impact Analysis
15. South Asia & Pacific Fluoropolymers Market for Healthcare Analysis 2015 – 2019 and Forecast 2020 – 2030
15.1. Introduction
15.2. Pricing Analysis
15.3. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2015 – 2019
15.4. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2018 - 2028
15.4.1.1. By Country
15.4.1.2. India
15.4.1.3. ASEAN
15.4.1.4. Australia & New Zealand
15.4.1.5. Rest of South Asia
15.4.2. By Product Type
15.4.3. By Application
15.5. Market Attractiveness Analysis
15.5.1. By Country
15.5.2. By Product Type
15.5.3. By Application
15.6. Market Trends
15.7. Key Market Participants - Intensity Mapping
15.8. Drivers and Restraints - Impact Analysis
16. East Asia Fluoropolymers Market for Healthcare Analysis 2015 – 2019 and Forecast 2020 – 2030
16.1. Introduction
16.2. Pricing Analysis
16.3. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2015 – 2019
16.4. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2018 - 2028
16.4.1.1. By Country
16.4.1.2. China
16.4.1.3. Japan
16.4.1.4. South Korea
16.4.2. By Product Type
16.4.3. By Application
16.5. Market Attractiveness Analysis
16.5.1. By Country
16.5.2. By Product Type
16.5.3. By Application
16.6. Market Trends
16.7. Key Market Participants - Intensity Mapping
16.8. Drivers and Restraints - Impact Analysis
17. Middle East and Africa Fluoropolymers Market for Healthcare Analysis 2015 – 2019 and Forecast 2020 – 2030
17.1. Introduction
17.2. Pricing Analysis
17.3. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2015 – 2019
17.4. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2018 - 2028
17.4.1.1. By Country
17.4.1.2. GCC Countries
17.4.1.3. South Africa
17.4.1.4. Turkey
17.4.1.5. Rest of Middle East and Africa
17.4.2. By Product Type
17.4.3. By Application
17.5. Market Attractiveness Analysis
17.5.1. By Country
17.5.2. By Product Type
17.5.3. By Application
17.6. Market Trends
17.7. Key Market Participants - Intensity Mapping
17.8. Drivers and Restraints - Impact Analysis
18. Key and Emerging Countries Fluoropolymers Market for Healthcare Analysis
18.1. Introduction
18.1.1. Market Value Proportion Analysis, By Key Countries
18.1.2. Global Vs. Country Growth Comparison
18.2. U.S. Fluoropolymers Market for Healthcare Analysis
18.2.1. By Product Type
18.2.2. By Application
18.3. Canada Fluoropolymers Market for Healthcare Analysis
18.3.1. By Product Type
18.3.2. By Application
18.4. Mexico Fluoropolymers Market for Healthcare Analysis
18.4.1. By Product Type
18.4.2. By Application
18.5. Brazil Fluoropolymers Market for Healthcare Analysis
18.5.1. By Product Type
18.5.2. By Application
18.6. Germany Fluoropolymers Market for Healthcare Analysis
18.6.1. By Product Type
18.6.2. By Application
18.7. Italy Fluoropolymers Market for Healthcare Analysis
18.7.1. By Product Type
18.7.2. By Application
18.8. France Fluoropolymers Market for Healthcare Analysis
18.8.1. By Product Type
18.8.2. By Application
18.9. U.K. Fluoropolymers Market for Healthcare Analysis
18.9.1. By Product Type
18.9.2. By Application
18.10. Spain Fluoropolymers Market for Healthcare Analysis
18.10.1. By Product Type
18.10.2. By Application
18.11. Russia Fluoropolymers Market for Healthcare Analysis
18.11.1. By Product Type
18.11.2. By Application
18.12. BENELUX Fluoropolymers Market for Healthcare Analysis
18.12.1. By Product Type
18.12.2. By Application
18.13. NORDICS Fluoropolymers Market for Healthcare Analysis
18.13.1. By Product Type
18.13.2. By Application
18.14. China Fluoropolymers Market for Healthcare Analysis
18.14.1. By Product Type
18.14.2. By Application
18.15. Japan Fluoropolymers Market for Healthcare Analysis
18.15.1. By Product Type
18.15.2. By Application
18.16. S. Korea Fluoropolymers Market for Healthcare Analysis
18.16.1. By Product Type
18.16.2. By Application
18.17. India Fluoropolymers Market for Healthcare Analysis
18.17.1. By Product Type
18.17.2. By Application
18.18. ASEAN Fluoropolymers Market for Healthcare Analysis
18.18.1. By Product Type
18.18.2. By Application
18.19. ANZ Fluoropolymers Market for Healthcare Analysis
18.19.1. By Product Type
18.19.2. By Application
18.20. GCC Countries Fluoropolymers Market for Healthcare Analysis
18.20.1. By Product Type
18.20.2. By Application
18.21. Turkey Fluoropolymers Market for Healthcare Analysis
18.21.1. By Product Type
18.21.2. By Application
18.22. Northern Africa Fluoropolymers Market for Healthcare Analysis
18.22.1. By Product Type
18.22.2. By Application
18.23. South Africa Fluoropolymers Market for Healthcare Analysis
18.23.1. By Product Type
18.23.2. By Application
19. Market Structure Analysis
19.1. Market Analysis by Tier of Companies (Fluoropolymers)
19.2. Market Concentration
19.3. Market Share Analysis of Key Players
19.4. Market Presence Analysis
19.4.1. By Regional footprint of Players
19.4.2. Product foot print by Players
19.4.3. Channel Foot Print by Players
20. Competition Analysis
20.1. Competition Dashboard
20.2. Pricing Analysis by Competition
20.3. Competition Benchmarking
20.4. Competition Deep Dive
20.4.1. The Chemours Company
20.4.1.1. Overview
20.4.1.2. Product Portfolio
20.4.1.3. Profitability by Market Segments (Product/Channel/Region)
20.4.1.4. Sales Footprint
20.4.1.5. Strategy Overview
20.4.1.5.1. Marketing Strategy
20.4.1.5.2. Product Strategy
20.4.1.5.3. Channel Strategy
20.4.2. Arkema Group
20.4.2.1. Overview
20.4.2.2. Product Portfolio
20.4.2.3. Profitability by Market Segments (Product/Channel/Region)
20.4.2.4. Sales Footprint
20.4.2.5. Strategy Overview
20.4.2.5.1. Marketing Strategy
20.4.2.5.2. Product Strategy
20.4.2.5.3. Channel Strategy
20.4.3. Solvay
20.4.3.1. Overview
20.4.3.2. Product Portfolio
20.4.3.3. Profitability by Market Segments (Product/Channel/Region)
20.4.3.4. Sales Footprint
20.4.3.5. Strategy Overview
20.4.3.5.1. Marketing Strategy
20.4.3.5.2. Product Strategy
20.4.3.5.3. Channel Strategy
20.4.4. DAIKIN INDUSTRIES, Ltd.
20.4.4.1. Overview
20.4.4.2. Product Portfolio
20.4.4.3. Profitability by Market Segments (Product/Channel/Region)
20.4.4.4. Sales Footprint
20.4.4.5. Strategy Overview
20.4.4.5.1. Marketing Strategy
20.4.4.5.2. Product Strategy
20.4.4.5.3. Channel Strategy
20.4.5. ASAHI GLASS CO., LTD.
20.4.5.1. Overview
20.4.5.2. Product Portfolio
20.4.5.3. Profitability by Market Segments (Product/Channel/Region)
20.4.5.4. Sales Footprint
20.4.5.5. Strategy Overview
20.4.5.5.1. Marketing Strategy
20.4.5.5.2. Product Strategy
20.4.5.5.3. Channel Strategy
20.4.6. 3M Company
20.4.6.1. Overview
20.4.6.2. Product Portfolio
20.4.6.3. Profitability by Market Segments (Product/Channel/Region)
20.4.6.4. Sales Footprint
20.4.6.5. Strategy Overview
20.4.6.5.1. Marketing Strategy
20.4.6.5.2. Product Strategy
20.4.6.5.3. Channel Strategy
20.4.7. Saint-Gobain
20.4.7.1. Overview
20.4.7.2. Product Portfolio
20.4.7.3. Profitability by Market Segments (Product/Channel/Region)
20.4.7.4. Sales Footprint
20.4.7.5. Strategy Overview
20.4.7.5.1. Marketing Strategy
20.4.7.5.2. Product Strategy
20.4.7.5.3. Channel Strategy
20.4.8. Dongyue Group Ltd.
20.4.8.1. Overview
20.4.8.2. Product Portfolio
20.4.8.3. Profitability by Market Segments (Product/Channel/Region)
20.4.8.4. Sales Footprint
20.4.8.5. Strategy Overview
20.4.8.5.1. Marketing Strategy
20.4.8.5.2. Product Strategy
20.4.8.5.3. Channel Strategy
20.4.9. Honeywell International Inc
20.4.9.1. Overview
20.4.9.2. Product Portfolio
20.4.9.3. Profitability by Market Segments (Product/Channel/Region)
20.4.9.4. Sales Footprint
20.4.9.5. Strategy Overview
20.4.9.5.1. Marketing Strategy
20.4.9.5.2. Product Strategy
20.4.9.5.3. Channel Strategy
20.4.10. Clariant
20.4.10.1. Overview
20.4.10.2. Product Portfolio
20.4.10.3. Profitability by Market Segments (Product/Channel/Region)
20.4.10.4. Sales Footprint
20.4.10.5. Strategy Overview
20.4.10.5.1. Marketing Strategy
20.4.10.5.2. Product Strategy
20.4.10.5.3. Channel Strategy
20.4.11. Mitsui Chemicals
20.4.11.1. Overview
20.4.11.2. Product Portfolio
20.4.11.3. Profitability by Market Segments (Product/Channel/Region)
20.4.11.4. Sales Footprint
20.4.11.5. Strategy Overview
20.4.11.5.1. Marketing Strategy
20.4.11.5.2. Product Strategy
20.4.11.5.3. Channel Strategy
20.4.12. Lonza Group
20.4.12.1. Overview
20.4.12.2. Product Portfolio
20.4.12.3. Profitability by Market Segments (Product/Channel/Region)
20.4.12.4. Sales Footprint
20.4.12.5. Strategy Overview
20.4.12.5.1. Marketing Strategy
20.4.12.5.2. Product Strategy
20.4.12.5.3. Channel Strategy
20.4.13. DIC Corporation
20.4.13.1. Overview
20.4.13.2. Product Portfolio
20.4.13.3. Profitability by Market Segments (Product/Channel/Region)
20.4.13.4. Sales Footprint
20.4.13.5. Strategy Overview
20.4.13.5.1. Marketing Strategy
20.4.13.5.2. Product Strategy
20.4.13.5.3. Channel Strategy
20.4.14. Polyone Corporation
20.4.14.1. Overview
20.4.14.2. Product Portfolio
20.4.14.3. Profitability by Market Segments (Product/Channel/Region)
20.4.14.4. Sales Footprint
20.4.14.5. Strategy Overview
20.4.14.5.1. Marketing Strategy
20.4.14.5.2. Product Strategy
20.4.14.5.3. Channel Strategy
20.4.15. Kaneka Corporation
20.4.15.1. Overview
20.4.15.2. Product Portfolio
20.4.15.3. Profitability by Market Segments (Product/Channel/Region)
20.4.15.4. Sales Footprint
20.4.15.5. Strategy Overview
20.4.15.5.1. Marketing Strategy
20.4.15.5.2. Product Strategy
20.4.15.5.3. Channel Strategy
21. Assumptions and Acronyms Used
22. Research Methodology
Let us know your requirement to get
100% FREE customization
List of Tables
Table 01: Global Fluoropolymers Market for Healthcare Size Volume (Tons) and Value (US$ Mn) Forecast by Product Type, 2015–2030
Table 02: Global Fluoropolymers Market for Healthcare Size Volume (Tons) Forecast by Application, 2015–2030
Table 03: Global Fluoropolymers Market for Healthcare Size Value (US$ Mn) Forecast by Application, 2015–2030
Table 04: Global Fluoropolymers Market for Healthcare Size Volume (KT) and Value (US$ Mn) Forecast by Region, 2015–2030
Table 05: North America Fluoropolymers Market for Healthcare Size (US$ Mn) and Volume (Tons) Forecast by Country, 2015–2030
Table 06: North America Fluoropolymers Market for Healthcare Size Volume (Tons) and Value (US$ Mn) Forecast by Product Type, 2015–2030
Table 07: North America Fluoropolymers Market for Healthcare Size Volume (Tons) Forecast by Application, 2015–2030
Table 08: North America Fluoropolymers Market for Healthcare Size Value (US$ Mn) Forecast by Application, 2015–2030
Table 09: Latin America Fluoropolymers Market for Healthcare Size (US$ Mn) and Volume (Tons) Forecast by Country, 2015–2030
Table 10: Latin America Fluoropolymers Market for Healthcare Size Volume (Tons) and Value (US$ Mn) Forecast by Product Type, 2015–2030
Table 11: Latin America Fluoropolymers Market for Healthcare Size Volume (Tons) Forecast by Application, 2015–2030
Table 12: Latin America Fluoropolymers Market for Healthcare Size Value (US$ Mn) Forecast by Application, 2015–2030
Table 13: Europe Fluoropolymers Market for Healthcare Size (US$ Mn) and Volume (Tons) Forecast by Country, 2015–2030
Table 14: Europe Fluoropolymers Market for Healthcare Size Volume (Tons) and Value (US$ Mn) Forecast by Product Type, 2015–2030
Table 15: Europe Fluoropolymers Market for Healthcare Size Volume (Tons) Forecast by Application, 2015–2030
Table 16: Europe Fluoropolymers Market for Healthcare Size Value (US$ Mn) Forecast by Application, 2015–2030
Table 17: East Asia Fluoropolymers Market for Healthcare Size (US$ Mn) and Volume (Tons) Forecast by Country, 2015–2030
Table 18: East Asia Fluoropolymers Market for Healthcare Size Volume (Tons) and Value (US$ Mn) Forecast by Product Type, 2015–2030
Table 19: East Asia Fluoropolymers Market for Healthcare Size Volume (Tons) Forecast by Application, 2015–2030
Table 20: East Asia Fluoropolymers Market for Healthcare Size Value (US$ Mn) Forecast by Application, 2015–2030
Table 21: South Asia Pacific Fluoropolymers Market for Healthcare Size (US$ Mn) and Volume (Tons) Forecast by Country, 2015–2030
Table 22: South Asia Pacific Fluoropolymers Market for Healthcare Size Volume (Tons) and Value (US$ Mn) Forecast by Product Type, 2015–2030
Table 23: South Asia Pacific Fluoropolymers Market for Healthcare Size Volume (Tons) Forecast by Application, 2015–2030
Table 24: South Asia Pacific Fluoropolymers Market for Healthcare Size Value (US$ Mn) Forecast by Application, 2015–2030
Table 26: MEA Fluoropolymers Market for Healthcare Size Volume (Tons) and Value (US$ Mn) Forecast by Product Type, 2015–2030
Table 27: MEA Fluoropolymers Market for Healthcare Size Volume (Tons) Forecast by Application, 2015–2030
Table 28: MEA Fluoropolymers Market for Healthcare Size Value (US$ Mn) Forecast by Application, 2015–2030
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystList of Charts
Figure 01: Global Historical Market Volume (KT) Analysis, 2015-2019
Figure 02: Global Current and Future Market Volume (KT) Analysis, 2020-2030
Figure 03: Fluoropolymers Market for Healthcare Historical Value (US$ Mn), 2015 – 2019
Figure 04: Fluoropolymers Market for Healthcare Value (US$ Mn) Forecast, 2020 – 2030
Figure 05: Fluoropolymers Market for Healthcare Absolute $ Opportunity, 2015 to 2020 and 2030
Figure 06: Global Fluoropolymers Market for Healthcare Share and BPS Analysis by Product Type– 2020 & 2030
Figure 07: Global Fluoropolymers Market for Healthcare Y-o-Y Growth Projections by Product Type, 2020 - 2030
Figure 08: Global Fluoropolymers Market for Healthcare Absolute $ Opportunity by PTFE Segment
Figure 09: Global Fluoropolymers Market for Healthcare Absolute $ Opportunity by PVDF Segment
Figure 10: Global Fluoropolymers Market for Healthcare Absolute $ Opportunity by PVF Segment
Figure 11: Global Fluoropolymers Market for Healthcare Absolute $ Opportunity by FEP Segment
Figure 12: Global Fluoropolymers Market for Healthcare Absolute $ Opportunity by PCTFE Segment
Figure 13: Global Fluoropolymers Market for Healthcare Absolute $ Opportunity by PFA Segment
Figure 14: Global Fluoropolymers Market for Healthcare Absolute $ Opportunity by Others Segment
Figure 15: Global Fluoropolymers Market for Healthcare Attractiveness Analysis by Product Type, 2020-2030
Figure 16: Global Fluoropolymers Market for Healthcare Share and BPS Analysis by Application– 2020 & 2030
Figure 17: Global Fluoropolymers Market for Healthcare Y-o-Y Growth Projections by Application, 2020 - 2030
Figure 18: Global Fluoropolymers Market for Healthcare Absolute $ Opportunity by Medical Devices Segment
Figure 19: Global Fluoropolymers Market for Healthcare Absolute $ Opportunity by Hospital Disposable Segment
Figure 20: Global Fluoropolymers Market for Healthcare Absolute $ Opportunity by Pharma Packaging Segment
Figure 21: Global Fluoropolymers Market for Healthcare Attractiveness Analysis by Application, 2020-2030
Figure 22: Global Fluoropolymers Market for Healthcare Share and BPS Analysis by Region– 2020 & 2030
Figure 23: Global Fluoropolymers Market for Healthcare Y-o-Y Growth Projections by Region, 2020 - 2030
Figure 24: Global Fluoropolymers Market for Healthcare Absolute $ Opportunity by North America Segment
Figure 25: Global Fluoropolymers Market for Healthcare Absolute $ Opportunity by Latin America Segment
Figure 26: Global Fluoropolymers Market for Healthcare Absolute $ Opportunity by Europe Segment
Figure 27: Global Fluoropolymers Market for Healthcare Absolute $ Opportunity by East Asia Segment
Figure 28: Global Fluoropolymers Market for Healthcare Absolute $ Opportunity by South Asia & Pacific Segment
Figure 29: Global Fluoropolymers Market for Healthcare Absolute $ Opportunity by MEA Segment
Figure 30: Global Fluoropolymers Market for Healthcare Attractiveness Analysis by Region, 2020-2030
Figure 31: North America Fluoropolymers Market for Healthcare Share and BPS Analysis by Country– 2020 & 2030
Figure 32: North America Fluoropolymers Market for Healthcare Y-o-Y Growth Projections by Country, 2020 - 2030
Figure 33: North America Fluoropolymers Market for Healthcare Attractiveness Analysis by Country, 2020-2030
Figure 34: North America Fluoropolymers Market for Healthcare Absolute $ Opportunity by U.S. Segment
Figure 35: North America Fluoropolymers Market for Healthcare Absolute $ Opportunity by Canada Segment
Figure 36: North America Fluoropolymers Market for Healthcare Share and BPS Analysis by Product Type– 2020 & 2030
Figure 37: North America Fluoropolymers Market for Healthcare Y-o-Y Growth Projections by Product Type, 2020 - 2030
Figure 38: North America Fluoropolymers Market for Healthcare Attractiveness Analysis by Product Type, 2020-2030
Figure 39: North America Fluoropolymers Market for Healthcare Share and BPS Analysis by Application– 2020 & 2030
Figure 40: North America Fluoropolymers Market for Healthcare Y-o-Y Growth Projections by Application, 2020 - 2030
Figure 41: North America Fluoropolymers Market for Healthcare Attractiveness Analysis by Application, 2020-2030
Figure 42: Latin America Fluoropolymers Market for Healthcare Share and BPS Analysis by Country– 2020 & 2030
Figure 43: Latin America Fluoropolymers Market for Healthcare Y-o-Y Growth Projections by Country, 2020 - 2030
Figure 44: Latin America Fluoropolymers Market for Healthcare Attractiveness Analysis by Country, 2020-2030
Figure 45: Latin America Fluoropolymers Market for Healthcare Absolute $ Opportunity by Brazil Segment
Figure 46: Latin America Fluoropolymers Market for Healthcare Absolute $ Opportunity by Mexico Segment
Figure 47: Latin America Fluoropolymers Market for Healthcare Absolute $ Opportunity by Brazil Segment
Figure 48: Latin America Fluoropolymers Market for Healthcare Share and BPS Analysis by Product Type– 2020 & 2030
Figure 49: Latin America Fluoropolymers Market for Healthcare Y-o-Y Growth Projections by Product Type, 2020 - 2030
Figure 50: Latin America Fluoropolymers Market for Healthcare Attractiveness Analysis by Product Type, 2020-2030
Figure 51: Latin America Fluoropolymers Market for Healthcare Share and BPS Analysis by Application– 2020 & 2030
Figure 52: Latin America Fluoropolymers Market for Healthcare Y-o-Y Growth Projections by Application, 2020 - 2030
Figure 53: Latin America Fluoropolymers Market for Healthcare Attractiveness Analysis by Application, 2020-2030
Figure 54: Europe Fluoropolymers Market for Healthcare Share and BPS Analysis by Country– 2020 & 2030
Figure 55: Europe Fluoropolymers Market for Healthcare Y-o-Y Growth Projections by Country, 2020 - 2030
Figure 56: Europe Fluoropolymers Market for Healthcare Attractiveness Analysis by Country, 2020-2030
Figure 57: Europe Fluoropolymers Market for Healthcare Absolute $ Opportunity by Germany Segment
Figure 58: Europe Fluoropolymers Market for Healthcare Absolute $ Opportunity by Italy Segment
Figure 59: Europe Fluoropolymers Market for Healthcare Absolute $ Opportunity by Germany Segment
Figure 60: Europe Fluoropolymers Market for Healthcare Absolute $ Opportunity by Italy Segment
Figure 61: Europe Fluoropolymers Market for Healthcare Absolute $ Opportunity by Germany Segment
Figure 62: Europe Fluoropolymers Market for Healthcare Absolute $ Opportunity by Italy Segment
Figure 63: Europe Fluoropolymers Market for Healthcare Absolute $ Opportunity by Germany Segment
Figure 64: Europe Fluoropolymers Market for Healthcare Absolute $ Opportunity by Italy Segment
Figure 65: Europe Fluoropolymers Market for Healthcare Share and BPS Analysis by Product Type– 2020 & 2030
Figure 66: Europe Fluoropolymers Market for Healthcare Y-o-Y Growth Projections by Product Type, 2020 - 2030
Figure 67: Europe Fluoropolymers Market for Healthcare Attractiveness Analysis by Product Type, 2020-2030
Figure 68: Europe Fluoropolymers Market for Healthcare Share and BPS Analysis by Application– 2020 & 2030
Figure 69: Europe Fluoropolymers Market for Healthcare Y-o-Y Growth Projections by Application, 2020 - 2030
Figure 70: Europe Fluoropolymers Market for Healthcare Attractiveness Analysis by Application, 2020-2030
Figure 71: East Asia Fluoropolymers Market for Healthcare Share and BPS Analysis by Country– 2020 & 2030
Figure 72: East Asia Fluoropolymers Market for Healthcare Y-o-Y Growth Projections by Country, 2020 - 2030
Figure 73: East Asia Fluoropolymers Market for Healthcare Attractiveness Analysis by Country, 2020-2030
Figure 74: East Asia Fluoropolymers Market for Healthcare Absolute $ Opportunity by China Segment
Figure 75: East Asia Fluoropolymers Market for Healthcare Absolute $ Opportunity by Japan Segment
Figure 76: East Asia Fluoropolymers Market for Healthcare Absolute $ Opportunity by China Segment
Figure 77: East Asia Fluoropolymers Market for Healthcare Share and BPS Analysis by Product Type– 2020 & 2030
Figure 78: East Asia Fluoropolymers Market for Healthcare Y-o-Y Growth Projections by Product Type, 2020 - 2030
Figure 79: East Asia Fluoropolymers Market for Healthcare Attractiveness Analysis by Product Type, 2020-2030
Figure 80: East Asia Fluoropolymers Market for Healthcare Share and BPS Analysis by Application– 2020 & 2030
Figure 81: East Asia Fluoropolymers Market for Healthcare Y-o-Y Growth Projections by Application, 2020 - 2030
Figure 82: East Asia Fluoropolymers Market for Healthcare Attractiveness Analysis by Application, 2020-2030
Figure 83: South Asia Pacific Fluoropolymers Market for Healthcare Share and BPS Analysis by Country– 2020 & 2030
Figure 84: South Asia Pacific Fluoropolymers Market for Healthcare Y-o-Y Growth Projections by Country, 2020 - 2030
Figure 85: South Asia Pacific Fluoropolymers Market for Healthcare Attractiveness Analysis by Country, 2020-2030
Figure 86: South Asia Pacific Fluoropolymers Market for Healthcare Absolute $ Opportunity by India Segment
Figure 87: South Asia Pacific Fluoropolymers Market for Healthcare Absolute $ Opportunity by ASEAN Segment
Figure 88: South Asia Pacific Fluoropolymers Market for Healthcare Absolute $ Opportunity by India Segment
Figure 89: South Asia Pacific Fluoropolymers Market for Healthcare Absolute $ Opportunity by ASEAN Segment
Figure 90: South Asia Pacific Fluoropolymers Market for Healthcare Share and BPS Analysis by Product Type– 2020 & 2030
Figure 91: South Asia Pacific Fluoropolymers Market for Healthcare Y-o-Y Growth Projections by Product Type, 2020 - 2030
Figure 92: South Asia Pacific Fluoropolymers Market for Healthcare Attractiveness Analysis by Product Type, 2020-2030
Figure 93: South Asia Pacific Fluoropolymers Market for Healthcare Share and BPS Analysis by Application– 2020 & 2030
Figure 94: South Asia Pacific Fluoropolymers Market for Healthcare Y-o-Y Growth Projections by Application, 2020 - 2030
Figure 95: South Asia Pacific Fluoropolymers Market for Healthcare Attractiveness Analysis by Application, 2020-2030
Figure 96: MEA Fluoropolymers Market for Healthcare Share and BPS Analysis by Country– 2020 & 2030
Figure 97: MEA Fluoropolymers Market for Healthcare Y-o-Y Growth Projections by Country, 2020 - 2030
Figure 98: MEA Fluoropolymers Market for Healthcare Attractiveness Analysis by Country, 2020-2030
Figure 99: MEA Fluoropolymers Market for Healthcare Absolute $ Opportunity by GCC Countries Segment
Figure 100: MEA Fluoropolymers Market for Healthcare Absolute $ Opportunity by Turkey Segment
Figure 101: MEA Fluoropolymers Market for Healthcare Absolute $ Opportunity by GCC Countries Segment
Figure 102: MEA Fluoropolymers Market for Healthcare Absolute $ Opportunity by Turkey Segment
Figure 103: MEA Fluoropolymers Market for Healthcare Absolute $ Opportunity by GCC Countries Segment
Figure 104: MEA Fluoropolymers Market for Healthcare Share and BPS Analysis by Product Type– 2020 & 2030
Figure 105: MEA Fluoropolymers Market for Healthcare Y-o-Y Growth Projections by Product Type, 2020 - 2030
Figure 106: MEA Fluoropolymers Market for Healthcare Attractiveness Analysis by Product Type, 2020-2030
Figure 107: MEA Fluoropolymers Market for Healthcare Share and BPS Analysis by Application– 2020 & 2030
Figure 108: MEA Fluoropolymers Market for Healthcare Y-o-Y Growth Projections by Application, 2020 - 2030
Figure 109: MEA Fluoropolymers Market for Healthcare Attractiveness Analysis by Application, 2020-2030
Need specific information?
Request CustomizationExplore Healthcare Insights
View Reports
